Interleukin-35 Mediates Mucosal Immune Responses That Protect Against T-Cell–Dependent Colitis

2011/08/06 by Stefan Wirtz, Ulrike Billmeier, Tamuna Mchedlidze +2 · 27 citations
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Adoptive cell transfer #Biology #Colitis #Cytokine #Disease #Immune system #Immunology #Inflammation #Inflammatory bowel disease #Internal medicine #Medicine #Pathogenesis #Psoriasis: Treatment and Pathogenesis #T cell #T-cell and B-cell Immunology #Virus-based gene therapy research

paper · doi:10.1053/j.gastro.2011.07.040

openalex publication_date 2011/08/06 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29

Cited by

• IL-35 Suppresses Lipopolysaccharide-Induced Airway Eosinophilia in EBI3-Deficient Mice
• IL-12 Family Cytokines in Cancer and Immunotherapy
• IL-12 family cytokines: immunological playmakers. [europepmc]
• Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance. [europepmc]
• Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy? [europepmc]
• IL-35: a potential therapeutic target for controlling hepatitis B virus infection. [europepmc]
• Cytokine-modulating strategies and newer cytokine targets for arthritis therapy. [europepmc]
• Endoplasmic reticulum stress in intestinal epithelial cell function and inflammatory bowel disease. [europepmc]
• Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis. [europepmc]
• Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature. [europepmc]
• Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders. [europepmc]
• Interleukin-35-Producing CD8α + Dendritic Cells Acquire a Tolerogenic State and Regulate T Cell Function. [europepmc]
• Interleukin 35 Polymorphisms Are Associated with Decreased Risk of Premature Coronary Artery Disease, Metabolic Parameters, and IL-35 Levels: The Genetics of Atherosclerotic Disease (GEA) Study. [europepmc]
• Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease. [europepmc]
• Interleukin-35 on B cell and T cell induction and regulation. [europepmc]
• Oral Escherichia coli expressing IL-35 meliorates experimental colitis in mice. [europepmc]
• Resolution of chronic inflammatory disease: universal and tissue-specific concepts. [europepmc]
• Increased serum IL-17 and decreased serum IL-10 and IL-35 levels correlate with the progression of COPD. [europepmc]
• Interleukin 30 to Interleukin 40. [europepmc]
• The Immunobiology of the Interleukin-12 Family: Room for Discovery. [europepmc]
• A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease. [europepmc]
• Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD. [europepmc]
• Regulatory T-cell therapy in Crohn's disease: challenges and advances. [europepmc]
• Regulatory B cells in cancer. [europepmc]
• IL-12 Family Cytokines in Cancer and Immunotherapy. [europepmc]
• Interleukin-35: Structure, Function and Its Impact on Immune-Related Diseases. [europepmc]
• CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease. [europepmc]